LRN vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

LRN

49.2
AI Score
VS
UTI Wins

UTI

53.0
AI Score

Investment Advisor Scores

LRN

49score
Recommendation
HOLD

UTI

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LRN UTI Winner
Forward P/E 10.7759 47.1698 LRN
PEG Ratio 0.5387 3.1448 LRN
Revenue Growth 2.7% 6.7% UTI
Earnings Growth -4.5% -96.3% LRN
Tradestie Score 49.2/100 53.0/100 UTI
Profit Margin 12.2% 4.9% LRN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LRN 1M: -9.3% · 3M: -17.4% UTI 1M: -16.4% · 3M: +4.7%

Current Technical Phase

LRN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.9%), weak momentum, RSI 39

RSI (14): 39.3 · Price: $80.29

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $39.31

Fundamentals Snapshot

Metric LRN UTI
Market Cap
Forward P/E 9.5 46.2
Trailing P/E 15.0 54.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.2% 0.0%
EPS 6.51 0.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.